Analyst Price Targets — SOLV
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 13, 2026 11:19 am | — | BTIG | $91.00 | $76.70 | TheFly | Solventum price target raised to $91 from $89 at BTIG |
| July 8, 2026 8:34 pm | — | BMO Capital | $81.00 | $75.18 | TheFly | BMO Capital starts Solventum at Market Perform amid 'many execution hurdles' |
| June 1, 2026 11:15 am | — | Jefferies | $43.00 | $74.95 | StreetInsider | SOLV Energy Inc (MWH) PT Raised to $43 at JefferiesMember Login |
| May 15, 2026 11:13 am | Michael Piccolo | Wedbush | $94.00 | $74.42 | TheFly | Solventum initiated with an Outperform at Wedbush |
| May 6, 2026 1:34 pm | Kevin Caliendo | UBS | $78.00 | $71.36 | TheFly | Solventum price target lowered to $78 from $82 at UBS |
| May 6, 2026 11:21 am | — | Stifel Nicolaus | $90.00 | $69.04 | TheFly | Solventum price target lowered to $90 from $105 at Stifel |
| May 6, 2026 10:29 am | Brett Fishbin | KeyBanc | $93.00 | $69.04 | TheFly | Solventum price target raised to $93 from $92 at KeyBanc |
| April 27, 2026 10:22 am | Brett Fishbin | KeyBanc | $92.00 | $68.52 | TheFly | Solventum price target lowered to $92 from $99 at KeyBanc |
| April 17, 2026 11:44 am | — | Piper Sandler | $92.00 | $68.88 | TheFly | Solventum price target lowered to $92 from $98 at Piper Sandler |
| January 26, 2026 1:51 am | Brett Fishbin | KeyBanc | $97.00 | $78.91 | TheFly | Solventum upgraded to Overweight from Sector Weight at KeyBanc |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for SOLV

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.

EAGAN, Minn., July 15, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its second quarter fiscal 2026 financial results on Wednesday, August 5, 2026, after the U.S. financial markets close.

Solventum Corporation continues to trade at a noticeable discount, with shares showing resilience versus med-tech peers despite tepid growth expectations. Management targets 3–4% underlying revenue growth for 2026, with SOLV EPS likely at the high end of the $6.40–$6.60 range. Restructuring and portfolio optimization offer significant upside, as SOLV's business units lack natural synergies and could be divested.

SOLV Energy remains a Buy as the backlog converts into higher-margin earnings, and the stock trades at a compelling valuation discount. MWH's $8.2B backlog and 1.2x book-to-bill offer strong near-term revenue visibility, with O&M and lifecycle services expanding long-term runway. The RWE acquisition strengthens MWH's grid-adjacent capabilities, enabling deeper customer relationships and a greater share of project…

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
